The multimodal antidepressant Lu AA21004: open-label long-term safety and tolerability study in major depressive disorder

被引：8
|
作者：
Florea, I. [1 ]
Dragheim, M. [1 ]
Loft, H. [2 ]
机构：
[1] H Lundbeck & Co AS, Mood & Anxiety Disorders, Copenhagen, Denmark
[2] H Lundbeck & Co AS, Biometr, Copenhagen, Denmark
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70383-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S255 / S256
页数：2
相关论文
共 50 条
  • [41] Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder
    Michael E. Thase
    Arielle D. Stanford
    Asli Memisoglu
    William Martin
    Amy Claxton
    J. Alexander Bodkin
    Madhukar H. Trivedi
    Maurizio Fava
    Miao Yu
    Sanjeev Pathak
    Neuropsychopharmacology, 2019, 44 : 2268 - 2276
  • [42] Sustained Remission With Adjunctive Brexpiprazole in Major Depressive Disorder: Post Hoc Analysis of a Long-Term, Open-Label, Extension Study
    Baker, Ross A.
    Weiss, Catherine
    Meehan, Stine R.
    Zhang, Peter
    Hobart, Mary
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S307 - S307
  • [43] Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder
    Thase, Michael E.
    Stanford, Arielle D.
    Memisoglu, Asli
    Martin, William
    Claxton, Amy
    Bodkin, J. Alexander
    Trivedi, Madhukar H.
    Fava, Maurizio
    Yu, Miao
    Pathak, Sanjeev
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (13) : 2268 - 2276
  • [44] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, T.
    Murray, R. M.
    Azorin, J. M.
    Maehlum, E.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 431 - 432
  • [45] AN OPEN-LABEL, LONG-TERM EVALUATION OF THE SAFETY AND TOLERABILITY OF AVANAFIL IN MEN WITH ERECTILE DYSFUNCTION
    Belkoff, L.
    McCullough, A.
    Goldstein, I
    Didonato, K.
    Trask, B.
    Bowden, C.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 396 - 396
  • [46] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, A.
    Murray, R. M.
    Azorin, J. M.
    Maehium, E.
    EUROPEAN PSYCHIATRY, 2007, 22 : S113 - S113
  • [47] A Long-Term Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults With Schizophrenia
    Forbes, Robert
    Hobart, Mary
    Ouyang, John
    Pfister, Stephanie
    Hakala, Mika
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S409 - S410
  • [48] Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
    Rajnish Mago
    Giovanna Forero
    William M. Greenberg
    Carl Gommoll
    Changzheng Chen
    Clinical Drug Investigation, 2013, 33 : 761 - 771
  • [49] Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
    Mago, Rajnish
    Forero, Giovanna
    Greenberg, William M.
    Gommoll, Carl
    Chen, Changzheng
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 761 - 771
  • [50] Safety and tolerability of levomilnacipran SR in major depressive disorder: results from an open-label, 48-week extension study
    Mago, R.
    Forero, G.
    Greenberg, W. M.
    Gommoll, C.
    Chen, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S330 - S330
12345